Teva Pharma (TEVA) Reports Approval, Launch of Generic Lovaza in U.S. (GSK)
Tweet Send to a Friend
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announces the approval of the generic equivalent to Lovaza ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
